References
- Arnett F. C, Edworthy S. M, Bloch D. A, McShane D. J, Fries J. F, Cooper N. S, Healey L. A, Kaplan S. R, Liang M. H, Luthra H. S, Medsger T. A., Jr, Mitchell D. M, Neustadt D. H, Pinals R. S, Schaller J. G, Sharp J. T, Wilder R. L., Hunder G. G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31: 315–324
- Bonifacio E., Genovcse S., Braghi S., Bazzigaluppi E., Lampasona V., Bingley P. J, Rogge L., Pastore M. R, Bognetti E., Bottazzo G. F, Gale E. A.M., Bosi E. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816–822
- Bradford M. A rapidsensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–254
- Karges W., Pietropaolo M., Ackerley C. A., Dosch H.-M. Gene expression of islet cell antigen p69 in human, mouse, rat. Diabetes 1996; 45: 513–521
- Kim J., Namchuk M., Bugawan T., Fu Q., Jaffe M., Shi Y., Aanstool H.-J., Turck C. W, Erlich H., Lennon V., Baekkeskov S. Higher autoantibody levelsrecognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish Stiff-Man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 1994; 180: 595–606
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Lampasona V., Ferrari M., Bosi E., Pastore M. R, Bingley P. J., Bonifacio E. Sera from patients with IDDMhealthy individuals have antibodies to ICA69 on Western blots but do not immunoprecipitate liquid phase antigen. J. Autoimmun. 1994; 7: 665–674
- Lan M. S, Wasserfall C., Maclaren N. K., Notkins A. L. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc., Natl. Acad. Sci. USA 1996; 93: 6367–6370
- Martin S., Kardorf J., Schulte B., Lampeter E. F, Gries F. A, Melchers I., Wagner R., Bertrams J., Roep B. O, Pfátzner A., Pietropaolo M., Kolb H. Autoantibodies to the islet antigen ICA69 occur in IDDMin rheumatoid arthritis. Diabetologia 1995; 38: 351–355
- Miyazaki I., Cheung R. K, Gaedigk R., Hui M. F, Van der Meulen J., Rajotte R. V., Dosch H.-M. T cell activationanergy to islet cell antigen in type 1 diabetes. J. Immunol. 1995; 154: 1461–1469
- Miyazaki I., Gaedigk R., Hui M. F, Cheung R. K, Morkowski J., Rajotte R. V., Dosch H.-M. Cloning of humanrat p69 cDNA, a candidate autoimmune target in type 1 diabetes. Biochim. Biophys. Acta 1994; 1227: 101–104
- O'Reilly D. R, Miller L. K., Luckov V. A. Baculovirus expression vectors. Laboratory Manual. FreemanCompany, New York 1992; 216–236
- Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y. -L.S., Martin S., Martin A., Powers A. C, Prochazka M., Naggert J., Leiter E. H., Eisenbarth G. S. Molecular cloningcharacterization of a novel diabetes-associated autoantigen. J. Clin. Invest. 1993; 92: 359–371
- Roep B. O, Duinkerken G., Schreuder G. M.T., Kolb H., de Vries R. R.P., Martin S. HLA-associated inverse correlation between T cellantibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur. J. Immunol. 1996; 26: 1285–1289
- Sabbah E., Kulmala P., Veijola R., Vähäsalo P., Karjalainen J., Tuomilehto-Wolf E., Åkerblom H. K, Knip M. and the Childhood Diabetes in Finland Study Group. Glutamic acid decarboxylase antibodies in relation LO other autoantibodiesgenetic risk markers in children with newly diagnosed insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 1996; 81: 2455–2459
- Soini E., Hemmilä I. Fluoroimmunoassay: present statusproblems. Clin. Chem. 1979; 25: 353–361
- Yamamoto Y., Mizuno R., Nishimura T., Ogawa Y., Yoshikawa H., Fujimura H., Adachi E., Kishimoto T., Yanagihara T., Sakoda S. Cloningexpression of myelin-associated basic protein. A novel basic protein constituting the central nervous system myelin. J. Biol. Chem. 1994; 269: 31725–31730